Antibody conjugated cyclodextrin for tumor drug delivery
Abzena company developed a series of antibody drug conjugates (ADCs) using IgG1, IgG2, IgG4, mAbs, and other antibodies modified with
A forum for researchers, students and applicants in the field of cyclodextrin technology
Abzena company developed a series of antibody drug conjugates (ADCs) using IgG1, IgG2, IgG4, mAbs, and other antibodies modified with
Several cyclodextrins have been claimed by dozens of papers including huge works of Serno [1] and Hartl [2] to be